SCLC, Recurrent
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (NCT04525391) | Se-Hoon Lee | 2020-09-18 |
Track SCLC, Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.